Pages that link to "Q24674937"
Jump to navigation
Jump to search
The following pages link to Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae (Q24674937):
Displaying 50 items.
- Plasmid-determined AmpC-type beta-lactamases (Q24535748) (← links)
- Sequence of the MIR-1 beta-lactamase gene (Q24550644) (← links)
- beta-Lactamases in laboratory and clinical resistance (Q24669605) (← links)
- A functional classification scheme for beta-lactamases and its correlation with molecular structure (Q24677460) (← links)
- Amino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase (Q30731622) (← links)
- Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals (Q33554703) (← links)
- Cephalosporin utilisation review and evaluation (Q33569493) (← links)
- Characterization of FOX-3, an AmpC-Type Plasmid-Mediated β-Lactamase from an Italian Isolate of Klebsiella oxytoca (Q33690231) (← links)
- beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. (Q33693251) (← links)
- Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. (Q33694016) (← links)
- Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri (Q33694083) (← links)
- Class A beta-lactamases--enzyme-inhibitor interactions and resistance (Q33746868) (← links)
- Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance (Q33747222) (← links)
- Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants (Q33759195) (← links)
- Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients. (Q33770088) (← links)
- The microbial genetics of antibiotic cycling (Q33827956) (← links)
- Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli (Q33856282) (← links)
- Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management (Q33928647) (← links)
- Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase (Q33938172) (← links)
- Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. (Q33966850) (← links)
- Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan (Q33970463) (← links)
- Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. (Q33976916) (← links)
- Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae (Q33977146) (← links)
- A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia (Q33977370) (← links)
- IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain (Q33980369) (← links)
- Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate (Q33983391) (← links)
- Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp (Q34041616) (← links)
- Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium (Q34047473) (← links)
- Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii (Q34107174) (← links)
- New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy (Q34192597) (← links)
- Controversies about extended-spectrum and AmpC beta-lactamases (Q34213755) (← links)
- Extended-spectrum beta-lactamases: epidemiology, detection, and treatment (Q34445641) (← links)
- Beta-lactamase nomenclature (Q34510623) (← links)
- Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. (Q34652460) (← links)
- Plasmid-borne AmpC beta-lactamases (Q34776284) (← links)
- In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae (Q35004824) (← links)
- Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002 (Q35073335) (← links)
- Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics (Q35111391) (← links)
- Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens (Q35112955) (← links)
- Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. (Q35122028) (← links)
- In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. (Q35122321) (← links)
- Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2). (Q35125797) (← links)
- Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be. (Q35132969) (← links)
- Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. (Q35133558) (← links)
- A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins (Q35138291) (← links)
- Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa (Q35814019) (← links)
- Comparative activity of several antimicrobial agents against nosocomial Gram-negative rods isolated across Canada (Q35816718) (← links)
- Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests (Q35896953) (← links)
- Genotypic and Phenotypic Detection of AmpC β-lactamases in Enterobacter spp. Isolated from a Teaching Hospital in Malaysia (Q35952543) (← links)
- Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers (Q35993279) (← links)